Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 102 entries
View as:

Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT03630692 Org: User:
Start: 03/25/16 End: 06/30/20 Due: 06/30/21

Satisfaction and QUality of Life After Breast REconstruction

Phase: N/A Priority: Normal
NCT ID: NCT04329819 Org: User:
Start: 09/03/19 End: 11/25/19 Due: 11/25/20

Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic

Phase: N/A Priority: Normal
NCT ID: NCT04421625 Org: User:
Start: 06/15/20 End: 06/28/22 Due: 06/28/23

Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation

Phase: N/A Priority: Normal
NCT ID: NCT03791736 Org: User:
Start: 07/06/16 End: 07/06/18 Due: 07/06/19

Rurality Adapted Physical Activity Sport Health

Phase: N/A Priority: Normal
NCT ID: NCT05981170 Org: User:
Start: 09/30/23 End: 03/31/25 Due: 03/31/26

Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures

Phase: N/A Priority: Normal
NCT ID: NCT05343975 Org: User:
Start: 03/02/22 End: 11/02/23 Due: 11/02/24

Clinico-biological Data Collection Study of Metastatic Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04944030 Org: User:
Start: 04/12/23 End: 10/31/31 Due: 10/31/32

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

Phase: N/A Priority: Normal
NCT ID: NCT04666961 Org: User:
Start: 02/03/21 End: 08/01/33 Due: 08/01/34

Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04644913 Org: User:
Start: 11/18/22 End: 01/29/23 Due: 01/29/24

Persistent Organic Pollutants and Breast Cancers (POPCASE)

Phase: N/A Priority: Normal
NCT ID: NCT02890095 Org: User:
Start: 01/31/16 End: 06/30/34 Due: 06/30/35

OP2C : Prialt® Observatory in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04321408 Org: User:
Start: 07/10/20 End: 09/30/27 Due: 09/30/28

Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01317433 Org: User:
Start: 12/29/10 End: 10/10/16 Due: 10/10/17

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03630666 Org: User:
Start: 12/04/18 End: 06/30/26 Due: 06/30/27

Prospective Study, Assessing Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06962163 Org: User:
Start: 06/30/25 End: 11/30/29 Due: 11/30/30

To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06800989 Org: User:
Start: 05/15/25 End: 08/15/27 Due: 08/15/28

Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06471465 Org: User:
Start: 12/31/24 End: 12/31/29 Due: 12/31/30

Intravenous Chemotherapy and Plant-based Dietary Supplements

Phase: N/A Priority: Normal
NCT ID: NCT03959618 Org: User:
Start: 04/02/19 End: 05/13/20 Due: 05/13/21

Assessment of safEty, Tolerability, Radiation Dosimetry, and Imaging Properties of 89Zr-labeled giRenTuximab (89Zr-Girentuximab) in patIents With Non-musclE-iNvasive Bladder CancEr (NMIBC)

Phase: N/A Priority: Normal
NCT ID: NCT04897763 Org: User:
Start: 10/01/21 End: 09/26/22 Due: 09/26/23

Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05856656 Org: User:
Start: 09/30/23 End: 09/30/25 Due: 09/30/26

Electrotherapy in the Management of Myofascial Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04936451 Org: User:
Start: 01/05/22 End: 04/14/23 Due: 04/14/24

Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03636776 Org: User:
Start: 12/29/16 End: 01/11/22 Due: 01/11/23

Time to Surgery and Survival Outcomes for Patients With Resected Colorectal Carcinoma: Multicenter Study (BIG RENAPE)

Phase: N/A Priority: Normal
NCT ID: NCT04916054 Org: User:
Start: 06/04/21 End: 03/10/22 Due: 03/10/23

Women at Risk of Breast Cancer and OLFM4

Phase: N/A Priority: Normal
NCT ID: NCT02653105 Org: User:
Start: 03/08/16 End: 02/28/26 Due: 02/28/27

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Phase: N/A Priority: Normal
NCT ID: NCT03951337 Org: User:
Start: 04/26/19 End: 01/31/26 Due: 01/31/27

Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03794388 Org: User:
Start: 03/19/19 End: 11/18/22 Due: 11/18/23